Oncotarget

Vol 11, No 5

February 4, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 5 of Oncotarget features Figure 2, "Survival curves in the KRAS, EGFR, and niche mutations cohorts," by Aramini, et al.

Table of Contents

Research Papers

Calcitriol and non-calcemic vitamin D analogue, 22-oxacalcitriol, attenuate developmental and pathological choroidal vasculature angiogenesis ex vivo and in vivo

Calcitriol and non-calcemic vitamin D analogue, 22-oxacalcitriol, attenuate developmental and pathological choroidal vasculature angiogenesis ex vivo and in vivo

https://doi.org/10.18632/oncotarget.27380

Stephanie L. Merrigan, Bomina Park, Zaheer Ali, Lasse D. Jensen, Timothy W. Corson,  and Breandán N. Kennedy
493-509
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease

Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease

https://doi.org/10.18632/oncotarget.27433

Manish Charan, Piyush Dravid, Maren Cam, Bhuvana Setty, Ryan D. Roberts, Peter J. Houghton,  and Hakan Cam
510-522
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Sphingomyelin phosphodiesterase 3 methylation and silencing in oral squamous cell carcinoma results in increased migration and invasion and altered stress response

Sphingomyelin phosphodiesterase 3 methylation and silencing in oral squamous cell carcinoma results in increased migration and invasion and altered stress response

https://doi.org/10.18632/oncotarget.27458

James Jabalee, Rebecca Towle, James Lawson, Christopher Dickman,  and Cathie Garnis
523-534
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib

Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib

https://doi.org/10.18632/oncotarget.27462

Raquel Carvalho Montenegro, Alison Howarth, Alessandro Ceroni, Vita Fedele, Batoul Farran, Felipe Pantoja Mesquita, Martin Frejno, Benedict-Tilman Berger, Stephanie Heinzlmeir, Heba Z. Sailem, Roberta Tesch, Daniel Ebner, Stefan Knapp, Rommel Burbano, Bernhard Kuster,  and Susanne Müller
535-549
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Overall survival in patients with lung adenocarcinoma harboring “niche” mutations: an observational study

Overall survival in patients with lung adenocarcinoma harboring “niche” mutations: an observational study

https://doi.org/10.18632/oncotarget.27472

Beatrice Aramini, Federico Banchelli, Stefania Bettelli, Samantha Manfredini, Roberto D’Amico, Valentina Masciale, Massimo Pinelli, Margherita Moretti, Alessandro Stefani, Federica Bertolini, Massimo Dominici, Uliano Morandi,  and Antonino Maiorana
550-559
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Podcast  |  Video Interview  |  Order a Reprint

Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas

Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas

https://doi.org/10.18632/oncotarget.27342

Salvatore Lopez, Emanuele Perrone, Stefania Bellone, Elena Bonazzoli, Burak Zeybek, Chanhee Han, Joan Tymon-Rosario, Gary Altwerger, Gulden Menderes, Anna Bianchi, Luca Zammataro, Aranzazu Manzano, Paola Manara, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, Francesco Raspagliesi, Roberto Angioli, Natalia Buza, Pei Hui, Heather M. Bond,  and Alessandro D. Santin
560-570
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Corrections

Correction: The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts

Correction: The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts

https://doi.org/10.18632/oncotarget.27440

Leonid Visochek, Dikla Atias, Itay Spektor, Asher Castiel, Talia Golan,  and Malka Cohen-Armon
571-572
Correction  |  PDF  |  How to cite

Correction: P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines

Correction: P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines

https://doi.org/10.18632/oncotarget.27475

Elpetra Timmermans-Sprang, Rob W.J. Collin, Arjen Henkes, Meike Philipsen,  and Jan A. Mol
573-573
Correction  |  PDF  |  How to cite


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC